
GLP-1 receptor agonists for weight management
WHAT IT DOES
GLP-1 receptor agonists mimic a naturally occurring gut hormone involved in appetite regulation. They slow gastric emptying, increase satiety, and reduce hunger signals in the brain, helping patients feel full sooner and eat less without relying solely on willpower.
KEY RESULTS
A large randomized controlled trial published in The New England Journal of Medicine showed that patients using a GLP-1 receptor agonist alongside lifestyle intervention achieved significantly greater and more sustained weight loss compared to lifestyle changes alone, with improvements maintained over time. NEJM
A systematic review of multiple clinical trials reported consistent reductions in body weight and appetite, with GLP-1 therapies demonstrating a favourable safety profile when medically supervised. PMC































